This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovations of Robert John Schmidt
Introduction
Robert John Schmidt is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of compounds that inhibit hyperlipidemia. His work is vital for addressing health issues related to cholesterol levels in mammals, including humans.
Latest Patents
Schmidt holds a patent for "Benzothiophenes for inhibiting hyperlipidemia." This patent relates to a series of compounds and pharmaceutical formulations that provide a method for inhibiting hyperlipidemia, especially hypercholesterolemia, and the associated pathological sequelae. He has 1 patent to his name, showcasing his innovative approach to tackling this health concern.
Career Highlights
Robert John Schmidt is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and healthcare solutions. His role at the company allows him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Schmidt has collaborated with notable colleagues, including Patrick Irving Eacho and Patricia Sue Foxworthy-Mason. These partnerships have likely enhanced his research efforts and contributed to the success of his innovations.
Conclusion
Robert John Schmidt's work in developing compounds to inhibit hyperlipidemia represents a significant advancement in pharmaceutical science. His contributions are essential for improving health outcomes related to cholesterol management.